Trials / Completed
CompletedNCT02062255
Impact of COX2 on Sera Biomarkers From Obese Subjects
A Phase 0, Investigator Initiated Study, Evaluating the Impact of COX2 Inhibition on Human Sera Biomarkers From Obese Subjects
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 126 (actual)
- Sponsor
- The University of Texas Health Science Center at San Antonio · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Obesity promotes worse outcome for post-menopausal breast cancer patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aspirin | |
| DIETARY_SUPPLEMENT | Omega 3 FFA |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2016-04-01
- Completion
- 2016-04-01
- First posted
- 2014-02-13
- Last updated
- 2016-10-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02062255. Inclusion in this directory is not an endorsement.